Fatma AYDIN, Alper BİLER, Cüneyt Eftal TANER, İbrahim Egemen ERTAŞ

Do Pre-treatment Neutrophil/Lymphocyte and Platelet/Lymphocyte Ratios Predict Success of Medical Treatment in Patients with Tubo-ovarian Abscess?

INTRODUCTION: To analyze the predictive value of inflammatory markers for medical treatment success in patients with tubo-ovarian abscess (TOA). METHODS: Patients with TOA between January 2008 and December 2016 were retrospectively reviewed at Tepecik Training and Research Hospital, Obstetrics and Gynaecology Department. A total of 180 patients were enrolled the study. Patients were compared on the basis of TOA size, demographic characteristics, and laboratory findings. As complete blood count parameters, white blood cell, neutrophil, lymphocyte, and platelet counts, hemoglobin, hematocrit, neutrophil/lymphocyte ratio (NLR), and platelet/lymphocyte ratio (PLR) were analysed. RESULTS: A total of 99 (55%) patients underwent surgical treatment due to unsuccessful medical treatment. Patients who required surgery had larger abscess size, higher mean age, higher mean white blood cell, neutrophil, lymphocyte, and platelet counts, and higher mean C-reactive protein level, NLR, and PLR (p

Tubo-Ovaryan Apse Tanılı Olgularda Tedavi Öncesi Nötrofil/Lenfosit ve Platelet/Lenfosit Oranları Medikal Tedavi Başarısını Predikte Eder mi?

GİRİŞ ve AMAÇ: Tubo-ovaryan apse (TOA) tanılı hastalarda enflamasyon belirteçlerinin medikal tedavi başarısındaki prediktif değerlerini analiz etmektir. YÖNTEM ve GEREÇLER: Tepecik Eğitim ve Araştırma Hastanesi Kadın Hastalıkları ve Doğum Kliniği’nde 2008- 2016 yılları arasında medikal ve cerrahi olarak tedavi edilmiş TOA tanılı 180 hasta retrospektif olarak değerlendirildi. Klinik, demografik, laboratuvar ve operasyon verileri hastaların tıbbi kayıtları incelenerek sağlandı. Medikal ve cerrahi tedavi uygulanan hastaların tedavi öncesi ve sonrası dönemde tam kan sayımı, C-reaktif protein (CRP) ve eritrosit sedimantasyon hızı (ESR) ölçümleri için kan örnekleri alınarak sonuçları karşılaştırıldı. Tam kan sayımı parametreleri olarak; lökosit sayısı, nötrofil, lenfosit, hemoglobin, hematokrit ve platelet değerleri ile nötrofil/lenfosit oranı (NLR) ve platelet/lenfosit oranları (PLR) incelendi. BULGULAR: Antibiyotik tedavisinin başarısız olmasından dolayı 99 (%55) hastaya cerrahi tedavi uygulandı. Hastaların ortalama yaşı, ortalama apse boyutu, tedavi öncesi ortalama lökosit sayısı, nötrofil sayısı, trombosit sayısı, NLR ve PLR oranları ile CRP değerleri cerrahi olarak tedavi edilen grupta daha yüksekti (p

PDF

___

1. Granberg S, Gjelland K, Ekerhovd E. The management of pelvic abscess. Best Pract Res Clin Obstet Gynaecol 2009; 23:667-8.

2. Chappell CA, Wiesenfeld HC. Pathogenesis, diagnosis, and management of severe pelvic inflammatory disease and tuboovarian abscess. Clin Obstet Gynecol 2012;55:893–903.

3. Vermeeren J, Te Lınde Rw. Intraabdominal rupture of pelvic abscesses. Am J Obstet Gynecol 1954; 68:402.

4. Pedowıtz P, Bloomfıeld Rd. Ruptured Adnexal Abscess (Tuboovarıan)With Generalızed Perıtonıtıs. Am J Obstet Gynecol 1964; 88:721.

5. Rosen M, Breitkopf D, Waud K. Tubo-ovarian abscess management options for women who desire fertility. Obstet Gynecol Surv 2009; 64:681.

6. Kinay T, Unlubilgin E, Cirik DA, et al. The value of ultrasonograhic tubo-ovarian abscess morphology in predicting whether patients will require surgical treatment. Int J Gynaecol Obstet 2016;135:77–81.

7. Topcu HO, Kokanali K, Guzel AI, et al. Risk factors for adverse clinical outcomes in patients with tubo-ovarian abscess. J Obstet Gynaecol 2015;35:699–702.

8. Gungorduk K, Guzel E, Asicioglu O, et al. Experience of tubo-ovarian abscess in western Turkey. Int J Gynecol Obstet 2014;124:45–50.

9. Inal ZO, Inal HA, Gorkem U. Experience of Tubo-Ovarian Abscess: A Retrospective Clinical Analysis of 318 Patients in a Single Tertiary Center in Middle Turkey. Surg Infect (Larchmt). 2018;19:54-60.

10. Oktem O., The Ovary Anatomy and Function throughout Human Life, Ann. N.Y. Acad. Sci. 1127: 1–9 (2008). New York Academy of Sciences.doi: 10.1196/annals.1434.009.

11. Saladin K., Human Anatomy, Second Edition, ISBN 978–0–07–294368–9, MHID 0–07–294368– 8,2008,S:736-767.

12. Yildirim M, Turkyilmaz E, Avsar AF. Preoperative Neutrophil-to-Lymphocyte Ratio Has a Better Predictive Capacity in Diagnosing Tubo- Ovarian Abscess. Gynecol Obstet Invest. 2015;80:234-9.

13. Bolat D, Topcu YK, Aydogdu O, et al. Neutrophil to Lymphocyte Ratio as a predictor of early penile prosthesis implant infection. Int Urol Nephrol 2017;49:947–53.

14. Zahorec R: Ratio of neutrophil to lymphocyte counts rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102: 5–14.

15. Kurtipek E, Bekci TT, Kesli R, et al. The role of neutrophil-lymphocyte ratio and plateletlymmphocyte ratio in exacerbation of chronic obstructive pulmonary disease. J Pak Med Assoc 2015;65:1283-7.

16. Ertas IE, Gungorduk K, Akman L, et al. Eur J Obstet Gynecol Reprod Biol. 2013 Nov;171(1):138- 4.

17. Gungorduk K, Ertaş IE, Ozdemir A, et al. Prognostic Significance of Retroperitoneal Lymphadenectomy, Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio in Primary Fallopian Tube Carcinoma: A Multicenter Study. Cancer Res Treat. 2015;47(3):480-8.

18. Paramanathan A, Saxena A, Morris DL: A systematic review and meta-analysis on the impact of pre-operative neutrophil lymphocyte ratio on long term outcomes after curative intent resection of solid tumours. Surg Oncol 2014; 23: 31–9.

19. Williams KA, Labidi-Galy SI, Terry KL, et al. Prognostic significance and predictors of the neutrophil-to-lymphocyte ratio in ovarian cancer. Gynecol Oncol 2014; 132: 542–50.

20. Chappell CA, Wiesenfeld HC. Pathogenesis, d,agnosis, and management of severe pelvic inflammatory diease and tuboovarian abcess. Clin Obster Gynecol 2012;55(4):893-903.

21. Varras M, Polyzos D, Perouli E, et al. Tuboovarian abscesses:spectrum of sonographic findings with surgical and pathological correlations: Clin Exp Obstet Gynecol 2003;30(2-3):117-21.

22. Seshadri S, Kirwan J, Neal T: Perimenopausal pneumococcal tubo-ovarian abscess – a case report and review. Infect Dis Obstet Gynecol 2004; 12: 27–30.

23. Topcu HO, Kokanali K, Guzel AI, et al. Risk factors for adverse clinical outcomes in patients with tubo-ovarian abscess. J Obstet Gynaecol 2015;35:699–702.

24. Reed SD, Landers DV, Sweet RL (1991) Antibiotic treatment of tuboovarian abscess: comparison of broad-spectrum β-lactam agents versus clindamycin-containing regimens. Am J Obstet Gynecol 164:1556–62.

25. Doganay M, Iskender C, Kilic S, et al. Treatment approaches in tubo-ovarian abscesses according to scoring system. Bratisl Lek Listy. 2011;112(4):200-3.

26. Dewitt J, Reining A, Allsworth JE, et al. Tuboovarian abscesses: is size associated with duration of hospitalization & complications? Obstet Gynecol Int. 2010;2010:847041.

27. Akkurt MO, Yalcin SE, Akkurt I, et al. The evaluation of risk factors for failed response to conservative treatment in tubo-ovarian abscesses. J Turk Ger Gynecol Assoc 2015; 16:226–30.

28. Ear T, McDonald PP. Cytokine generation, promoter activation, and oxidant-independent NFkappaB activation in a transfectable human neutrophilic cellular model. BMC Immunol. 2008;9:14.

29. Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol. 2013;13:159-75.

30. Klinger Mh, Jelkman W. Role of blood platelets in infection and. İnflamation. J Interferon Cytokine Res. 2002;22:913-22.